Insiders · IDYA

Stuart Dorman

Chief Commercial Officer at IDEAYA Biosciences, Inc. (IDYA) since December 2024

Stuart Dorman has filed 3 insider reports with the SEC since December 2024, as chief Commercial Officer at IDEAYA Biosciences, Inc. (IDYA). The latest filing, on February 3, 2026, reports grant or award at IDEAYA Biosciences, Inc. (IDYA).

Filings
3
Companies
1
Bought on market
None
Sold on market
None

Companies where Stuart Dorman is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
IDEAYA Biosciences, Inc. logo
IDYA
IDEAYA Biosciences, Inc.
Chief Commercial Officersince December 2024$25.56Feb 3, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Stuart Dorman with

Other insiders at the same companies

Questions about Stuart Dorman

What is Stuart Dorman's role at IDEAYA Biosciences, Inc.?
Stuart Dorman reports to the SEC as chief Commercial Officer at IDEAYA Biosciences, Inc. (IDYA), according to the latest filing on February 3, 2026.
Has Stuart Dorman bought or sold stock recently?
No open-market purchases or sales by Stuart Dorman are on file. The filings report grant or award.
How do I get alerts when Stuart Dorman files?
Follow Stuart Dorman on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Stuart Dorman (SEC CIK 0002047580). Totals count each trade once, skipping amendments whose original is on file, from Dec 20, 2024 on. View on SEC EDGAR · Get this as JSON